調査レポート | • レポートコード：QYR2104Z2270 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、外分泌膵臓機能不全のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（栄養管理、膵臓酵素補充療法（PERT）、ライフスタイル修正アプローチ）、用途別市場規模（磁気共鳴画像法（MRI）、CTスキャン、超音波内視鏡検査（EUS）、血液検査、その他検査）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・外分泌膵臓機能不全の市場動向 ・企業の競争状況、市場シェア ・外分泌膵臓機能不全の種類別市場規模（栄養管理、膵臓酵素補充療法（PERT）、ライフスタイル修正アプローチ） ・外分泌膵臓機能不全の用途別市場規模（磁気共鳴画像法（MRI）、CTスキャン、超音波内視鏡検査（EUS）、血液検査、その他検査） ・外分泌膵臓機能不全の北米市場規模2016-2027（アメリカ、カナダ） ・外分泌膵臓機能不全のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・外分泌膵臓機能不全のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・外分泌膵臓機能不全の中南米市場規模2016-2027（メキシコ、ブラジル） ・外分泌膵臓機能不全の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Axcan Pharma、Aptalis Pharma、Eli Lilly、Cilian、Nordmark Arzneimittel、Laboratoires Mayoly Spindler） ・結論 |
Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.
EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.
Market Analysis and Insights: Global Exocrine Pancreatic Insufficiency Market
The global Exocrine Pancreatic Insufficiency market size is projected to reach US$ 2644.6 million by 2026, from US$ 2015.4 million in 2019, at a CAGR of 3.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exocrine Pancreatic Insufficiency market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exocrine Pancreatic Insufficiency market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exocrine Pancreatic Insufficiency market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exocrine Pancreatic Insufficiency market.
Global Exocrine Pancreatic Insufficiency Scope and Market Size
Exocrine Pancreatic Insufficiency market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Exocrine Pancreatic Insufficiency market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nutritional management
Pancreatic enzyme replacement therapy (PERT)
Life style modifications approach
Segment by Application
Magnetic resonance imaging (MRI)
CT scanning
Endoscopic ultrasonography (EUS)
Blood tests
Other tests
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Axcan Pharma
Aptalis Pharma
Eli Lilly
Cilian
Nordmark Arzneimittel
Laboratoires Mayoly Spindler
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nutritional management
1.2.3 Pancreatic enzyme replacement therapy (PERT)
1.2.4 Life style modifications approach
1.3 Market by Application
1.3.1 Global Exocrine Pancreatic Insufficiency Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Magnetic resonance imaging (MRI)
1.3.3 CT scanning
1.3.4 Endoscopic ultrasonography (EUS)
1.3.5 Blood tests
1.3.6 Other tests
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Exocrine Pancreatic Insufficiency Market Perspective (2016-2027)
2.2 Exocrine Pancreatic Insufficiency Growth Trends by Regions
2.2.1 Exocrine Pancreatic Insufficiency Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Exocrine Pancreatic Insufficiency Historic Market Share by Regions (2016-2021)
2.2.3 Exocrine Pancreatic Insufficiency Forecasted Market Size by Regions (2022-2027)
2.3 Exocrine Pancreatic Insufficiency Industry Dynamic
2.3.1 Exocrine Pancreatic Insufficiency Market Trends
2.3.2 Exocrine Pancreatic Insufficiency Market Drivers
2.3.3 Exocrine Pancreatic Insufficiency Market Challenges
2.3.4 Exocrine Pancreatic Insufficiency Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exocrine Pancreatic Insufficiency Players by Revenue
3.1.1 Global Top Exocrine Pancreatic Insufficiency Players by Revenue (2016-2021)
3.1.2 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Players (2016-2021)
3.2 Global Exocrine Pancreatic Insufficiency Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Exocrine Pancreatic Insufficiency Revenue
3.4 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio
3.4.1 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exocrine Pancreatic Insufficiency Revenue in 2020
3.5 Exocrine Pancreatic Insufficiency Key Players Head office and Area Served
3.6 Key Players Exocrine Pancreatic Insufficiency Product Solution and Service
3.7 Date of Enter into Exocrine Pancreatic Insufficiency Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exocrine Pancreatic Insufficiency Breakdown Data by Type
4.1 Global Exocrine Pancreatic Insufficiency Historic Market Size by Type (2016-2021)
4.2 Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Type (2022-2027)
5 Exocrine Pancreatic Insufficiency Breakdown Data by Application
5.1 Global Exocrine Pancreatic Insufficiency Historic Market Size by Application (2016-2021)
5.2 Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Exocrine Pancreatic Insufficiency Market Size (2016-2027)
6.2 North America Exocrine Pancreatic Insufficiency Market Size by Type
6.2.1 North America Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021)
6.2.2 North America Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027)
6.2.3 North America Exocrine Pancreatic Insufficiency Market Size by Type (2016-2027)
6.3 North America Exocrine Pancreatic Insufficiency Market Size by Application
6.3.1 North America Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021)
6.3.2 North America Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027)
6.3.3 North America Exocrine Pancreatic Insufficiency Market Size by Application (2016-2027)
6.4 North America Exocrine Pancreatic Insufficiency Market Size by Country
6.4.1 North America Exocrine Pancreatic Insufficiency Market Size by Country (2016-2021)
6.4.2 North America Exocrine Pancreatic Insufficiency Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Exocrine Pancreatic Insufficiency Market Size (2016-2027)
7.2 Europe Exocrine Pancreatic Insufficiency Market Size by Type
7.2.1 Europe Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021)
7.2.2 Europe Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027)
7.2.3 Europe Exocrine Pancreatic Insufficiency Market Size by Type (2016-2027)
7.3 Europe Exocrine Pancreatic Insufficiency Market Size by Application
7.3.1 Europe Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021)
7.3.2 Europe Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027)
7.3.3 Europe Exocrine Pancreatic Insufficiency Market Size by Application (2016-2027)
7.4 Europe Exocrine Pancreatic Insufficiency Market Size by Country
7.4.1 Europe Exocrine Pancreatic Insufficiency Market Size by Country (2016-2021)
7.4.2 Europe Exocrine Pancreatic Insufficiency Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size (2016-2027)
8.2 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Type
8.2.1 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Type (2016-2027)
8.3 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Application
8.3.1 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Application (2016-2027)
8.4 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region
8.4.1 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Exocrine Pancreatic Insufficiency Market Size (2016-2027)
9.2 Latin America Exocrine Pancreatic Insufficiency Market Size by Type
9.2.1 Latin America Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021)
9.2.2 Latin America Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027)
9.2.3 Latin America Exocrine Pancreatic Insufficiency Market Size by Type (2016-2027)
9.3 Latin America Exocrine Pancreatic Insufficiency Market Size by Application
9.3.1 Latin America Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021)
9.3.2 Latin America Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027)
9.3.3 Latin America Exocrine Pancreatic Insufficiency Market Size by Application (2016-2027)
9.4 Latin America Exocrine Pancreatic Insufficiency Market Size by Country
9.4.1 Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2016-2021)
9.4.2 Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size (2016-2027)
10.2 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Type
10.2.1 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Type (2016-2027)
10.3 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Application
10.3.1 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Application (2016-2027)
10.4 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country
10.4.1 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Axcan Pharma
11.1.1 Axcan Pharma Company Details
11.1.2 Axcan Pharma Business Overview
11.1.3 Axcan Pharma Exocrine Pancreatic Insufficiency Introduction
11.1.4 Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021)
11.1.5 Axcan Pharma Recent Development
11.2 Aptalis Pharma
11.2.1 Aptalis Pharma Company Details
11.2.2 Aptalis Pharma Business Overview
11.2.3 Aptalis Pharma Exocrine Pancreatic Insufficiency Introduction
11.2.4 Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021)
11.2.5 Aptalis Pharma Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Exocrine Pancreatic Insufficiency Introduction
11.3.4 Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Cilian
11.4.1 Cilian Company Details
11.4.2 Cilian Business Overview
11.4.3 Cilian Exocrine Pancreatic Insufficiency Introduction
11.4.4 Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021)
11.4.5 Cilian Recent Development
11.5 Nordmark Arzneimittel
11.5.1 Nordmark Arzneimittel Company Details
11.5.2 Nordmark Arzneimittel Business Overview
11.5.3 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Introduction
11.5.4 Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021)
11.5.5 Nordmark Arzneimittel Recent Development
11.6 Laboratoires Mayoly Spindler
11.6.1 Laboratoires Mayoly Spindler Company Details
11.6.2 Laboratoires Mayoly Spindler Business Overview
11.6.3 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Introduction
11.6.4 Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021)
11.6.5 Laboratoires Mayoly Spindler Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nutritional management
Table 3. Key Players of Pancreatic enzyme replacement therapy (PERT)
Table 4. Key Players of Life style modifications approach
Table 5. Global Exocrine Pancreatic Insufficiency Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Exocrine Pancreatic Insufficiency Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Exocrine Pancreatic Insufficiency Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Exocrine Pancreatic Insufficiency Market Share by Regions (2016-2021)
Table 9. Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Exocrine Pancreatic Insufficiency Market Share by Regions (2022-2027)
Table 11. Exocrine Pancreatic Insufficiency Market Trends
Table 12. Exocrine Pancreatic Insufficiency Market Drivers
Table 13. Exocrine Pancreatic Insufficiency Market Challenges
Table 14. Exocrine Pancreatic Insufficiency Market Restraints
Table 15. Global Exocrine Pancreatic Insufficiency Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Exocrine Pancreatic Insufficiency Market Share by Players (2016-2021)
Table 17. Global Top Exocrine Pancreatic Insufficiency Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exocrine Pancreatic Insufficiency as of 2020)
Table 18. Ranking of Global Top Exocrine Pancreatic Insufficiency Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Exocrine Pancreatic Insufficiency Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Exocrine Pancreatic Insufficiency Product Solution and Service
Table 22. Date of Enter into Exocrine Pancreatic Insufficiency Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type (2016-2021)
Table 26. Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Exocrine Pancreatic Insufficiency Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Application (2016-2021)
Table 30. Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Exocrine Pancreatic Insufficiency Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Exocrine Pancreatic Insufficiency Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Exocrine Pancreatic Insufficiency Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Exocrine Pancreatic Insufficiency Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2022-2027) & (US$ Million)
Table 62. Axcan Pharma Company Details
Table 63. Axcan Pharma Business Overview
Table 64. Axcan Pharma Exocrine Pancreatic Insufficiency Product
Table 65. Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021) & (US$ Million)
Table 66. Axcan Pharma Recent Development
Table 67. Aptalis Pharma Company Details
Table 68. Aptalis Pharma Business Overview
Table 69. Aptalis Pharma Exocrine Pancreatic Insufficiency Product
Table 70. Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021) & (US$ Million)
Table 71. Aptalis Pharma Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Exocrine Pancreatic Insufficiency Product
Table 75. Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Cilian Company Details
Table 78. Cilian Business Overview
Table 79. Cilian Exocrine Pancreatic Insufficiency Product
Table 80. Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021) & (US$ Million)
Table 81. Cilian Recent Development
Table 82. Nordmark Arzneimittel Company Details
Table 83. Nordmark Arzneimittel Business Overview
Table 84. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Product
Table 85. Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021) & (US$ Million)
Table 86. Nordmark Arzneimittel Recent Development
Table 87. Laboratoires Mayoly Spindler Company Details
Table 88. Laboratoires Mayoly Spindler Business Overview
Table 89. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Product
Table 90. Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2016-2021) & (US$ Million)
Table 91. Laboratoires Mayoly Spindler Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exocrine Pancreatic Insufficiency Market Share by Type: 2020 VS 2027
Figure 2. Nutritional management Features
Figure 3. Pancreatic enzyme replacement therapy (PERT) Features
Figure 4. Life style modifications approach Features
Figure 5. Global Exocrine Pancreatic Insufficiency Market Share by Application: 2020 VS 2027
Figure 6. Magnetic resonance imaging (MRI) Case Studies
Figure 7. CT scanning Case Studies
Figure 8. Endoscopic ultrasonography (EUS) Case Studies
Figure 9. Blood tests Case Studies
Figure 10. Other tests Case Studies
Figure 11. Exocrine Pancreatic Insufficiency Report Years Considered
Figure 12. Global Exocrine Pancreatic Insufficiency Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Exocrine Pancreatic Insufficiency Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Exocrine Pancreatic Insufficiency Market Share by Regions: 2020 VS 2027
Figure 15. Global Exocrine Pancreatic Insufficiency Market Share by Regions (2022-2027)
Figure 16. Global Exocrine Pancreatic Insufficiency Market Share by Players in 2020
Figure 17. Global Top Exocrine Pancreatic Insufficiency Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exocrine Pancreatic Insufficiency as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Exocrine Pancreatic Insufficiency Revenue in 2020
Figure 19. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type (2016-2021)
Figure 20. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type (2022-2027)
Figure 21. North America Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Exocrine Pancreatic Insufficiency Market Share by Type (2016-2027)
Figure 23. North America Exocrine Pancreatic Insufficiency Market Share by Application (2016-2027)
Figure 24. North America Exocrine Pancreatic Insufficiency Market Share by Country (2016-2027)
Figure 25. United States Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Exocrine Pancreatic Insufficiency Market Share by Type (2016-2027)
Figure 29. Europe Exocrine Pancreatic Insufficiency Market Share by Application (2016-2027)
Figure 30. Europe Exocrine Pancreatic Insufficiency Market Share by Country (2016-2027)
Figure 31. Germany Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Exocrine Pancreatic Insufficiency Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Exocrine Pancreatic Insufficiency Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Exocrine Pancreatic Insufficiency Market Share by Region (2016-2027)
Figure 41. China Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Exocrine Pancreatic Insufficiency Market Share by Type (2016-2027)
Figure 49. Latin America Exocrine Pancreatic Insufficiency Market Share by Application (2016-2027)
Figure 50. Latin America Exocrine Pancreatic Insufficiency Market Share by Country (2016-2027)
Figure 51. Mexico Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Exocrine Pancreatic Insufficiency Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Exocrine Pancreatic Insufficiency Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Exocrine Pancreatic Insufficiency Market Share by Country (2016-2027)
Figure 57. Turkey Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Exocrine Pancreatic Insufficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Axcan Pharma Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2016-2021)
Figure 61. Aptalis Pharma Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2016-2021)
Figure 63. Cilian Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2016-2021)
Figure 64. Nordmark Arzneimittel Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2016-2021)
Figure 65. Laboratoires Mayoly Spindler Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の外分泌膵臓機能不全市場規模・現状・予測（2021年-2027年） Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic ce…- 世界の外分泌膵機能不全（EPI）市場規模・現状・予測（2021年-2027年） Exocrine pancreatic insufficiency (EPI) refers to the condition wherein the body is unable to produce sufficient amounts of exocrine pancreatic enzymes, thus leading to difficulties in digesting food properly. The condition occurs due to the lack of sufficient enzymes necessary for fat digestion, am…
- 膵酵素補充療法（PERT）の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Pancreatic Enzyme Replacement Therapies (PERTs) from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price…
- 世界の膵臓＆胆管結石管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic and Bile Duct Stone Management Market The global Pancreatic and Bile Duct Stone Management market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …